PetVivo Holdings, Inc. (OTCQX: PETV) is making waves in the veterinary world with an exciting new partnership that could change how vets connect with pet owners, especially the younger, tech-savvy generation known as Gen Z. The company just signed an exclusive 10-year licensing agreement with Digital Landia Holding Corp to use their breakthrough Agentic Pet AI technology. This is no ordinary tech. It’s designed to tackle two huge problems in the veterinary field today: the skyrocketing costs to bring in new clients and how to effectively reach Gen Z pet parents, who are quickly becoming the biggest segment of pet owners in the US.
Why does this matter so much? Well, Gen Z and Millennials now account for 57% of all pet parents in America, and their approach to pet care is different. These younger generations often see their pets as actual family members or even children, which means they want personalized, data-driven care for their furry friends. However, many veterinary clinics have been slow to adapt their marketing and services to meet these new expectations, often still focusing on older pet owners through traditional marketing channels. This creates a disconnect, and potential clients are slipping through the cracks.
Enter the Agentic Pet AI technology. PetVivo’s partnership with Digital Landia is creating a two-sided platform that connects these tech-forward pet parents with forward-thinking veterinary practices. On one side, pet owners get access to a freemium app powered by nine specialized AI diagnostic agents. These smart agents track everything from symptoms and behavior to nutrition and wellness. The app’s basic version is free to use, while a premium subscription priced at $9.99 a month offers advanced diagnostics, breed-specific monitoring, and comprehensive health reports that help pet parents stay on top of their pets’ wellbeing.
But the real magic happens when pet parents opt to share their data with nearby vets. Their complete health data, gathered by the AI, flows directly to participating veterinary practices via PetVivo’s B2B platform. This seamless data transfer not only eliminates the hassle of intake forms and manual history taking but also equips vets with instant, AI-generated insights that can improve diagnosis and treatment plans. The platform continuously supports all patients, including walk-ins, offering real-time symptom analysis, behavioral pattern recognition, and emergency triage assessments.
The financial benefits for vets are equally impressive. Client acquisition costs are expected to drop by 90% to 98%. For example, one veterinarian, Dr. Martinez, lowered his client acquisition cost to $3.50 per Gen Z client using this platform, compared to the traditional $80 to $120. Beyond the savings, the platform boosts consultation efficiency by 20% and increases preventive care visits by 30%, thanks to earlier identification of health issues aided by AI.
From a broader market perspective, PetVivo is positioned to benefit significantly. The veterinary AI market in the U.S. is valued at $4.9 billion, with over 30,000 clinics potentially addressable through this technology. PetVivo already has relationships with more than 1,000 veterinary clinics, allowing for swift network expansion and distribution. The company reported a strong momentum with a 141% year-over-year growth in the first quarter of fiscal 2026 and generated $1.13 million in revenue in fiscal 2025.
This exclusive 10-year deal also comes with strategic investments, including 1 million restricted shares, backed by five patent-pending innovations that power the AI diagnostic agents. The dual launch combining Digital Landia’s B2C Agentic Pet app and PetVivo’s B2B platform early next year is expected to create immediate network effects, making the platform even more valuable as more users and vets join.
Beyond the AI platform, PetVivo is a company known for innovative animal health products like SPRYNG, which features OsteoCushion technology for managing joint issues such as osteoarthritis in pets, and PrecisePRP, a platelet-rich plasma product designed for veterinary use. Their focus on leveraging human therapies to accelerate animal health product commercialization shows their commitment to pioneering new ways to improve animal care.
On the AI side, Digital Landia’s Agentic Pet AI framework uses multi-modal data, including audio, video, lab results, and IoT sensors, combined with swarm intelligence to redefine personalized pet care. The AI autonomously evolves “super agents” that offer real-time, actionable insights across the full spectrum of pet wellbeing.
PetVivo’s new partnership brings a powerful blend of technology and veterinary expertise to meet the needs of the new generation of pet parents. By drastically reducing marketing costs and enhancing patient care through AI diagnostics and seamless data sharing, they are looking to set a new standard for veterinary care that benefits both vets and pet owners alike.
